Trending...
- American Garden Rose Selections™ Announces 2027 Winners
- Oral statement on the situation of Chairman Lee Man-hee in pretrial detention in the Republic of Korea
- Nutriband (N A S D A Q: NTRB): Fighting Back Against the Fentanyl Crisis With a New Approach to Safer Transdermal Medicines
COLUMBIA, Md. - Marylandian -- Columbia, MD—The founder, Dr. Jun Hayashi, and the CEO, Dr. Ginette Serrero, of Precision Antibody, a leading service provider for custom monoclonal antibody development, will be the chief speakers at "Drug Discovery Strategic Summit (DDSS) 2025" that will take place between April 30 - May 1 2025 in Boston, Massachusetts.
The passionate leaders and innovators from the pharmaceutical and biotech sector share their visionary thoughts at the Drug Discovery Strategic Summit. The latest advancements in drug discovery, current challenges, preclinical development, and translational science will be the focus topics of the summit.
Both Dr. Jun and Dr. Ginette will shed light on the vital role of high-affinity and high-specificity monoclonal antibodies in speeding the process of drug discovery and improvements in translational science. They will also share key insights from their two decades of experience in the field of antibody discovery and its development.
More on Marylandian
"The mission of Precision Antibody is to make reliable antibodies that help researchers carry forward the innovation and advancements," said Dr. Serrero. "It is my pleasure that I am honored to speak at DDSS, a global platform for conversation on therapeutic research," said Dr. Hayashi.
About Precision Antibody
The company has more than two decades of experience in providing personalized services for monoclonal and polyclonal antibody development. It was founded in 2000, and now it is a global leader in delivering solutions for therapeutic and research purposes. It is also equipped to tackle antibody requirements for oncology, immunology, and regenerative medicine. The deal with academic research centers and worldwide pharma companies.
Media Contact:
Precision Antibody
Dr. Jun Hayashi
President
Phone: 410-884-4100
Email: info@precisionantibody.com
Website: www.precisionantibody.com
Event Details:
Drug Discovery Strategic Summit (DDSS)
Dates: April 30 – May 1, 2025
Venue: Boston, MA
Event Website: https://ddss.agilefalconsg.com/
The passionate leaders and innovators from the pharmaceutical and biotech sector share their visionary thoughts at the Drug Discovery Strategic Summit. The latest advancements in drug discovery, current challenges, preclinical development, and translational science will be the focus topics of the summit.
Both Dr. Jun and Dr. Ginette will shed light on the vital role of high-affinity and high-specificity monoclonal antibodies in speeding the process of drug discovery and improvements in translational science. They will also share key insights from their two decades of experience in the field of antibody discovery and its development.
More on Marylandian
- Maryland: Veterinary Technician Committee Meeting Notice
- Maryland: Governor's Intergovernmental Commission for Agriculture Meeting
- Maryland: Invasive Plant Advisory Committee (IPAC) Meeting Notice
- Maryland: Funding Now Available for Fall Manure Transport and Injection Grants
- CardsNearby Launches Free Nationwide Directory of Card Shows and Local Card Shops for Collectors
"The mission of Precision Antibody is to make reliable antibodies that help researchers carry forward the innovation and advancements," said Dr. Serrero. "It is my pleasure that I am honored to speak at DDSS, a global platform for conversation on therapeutic research," said Dr. Hayashi.
About Precision Antibody
The company has more than two decades of experience in providing personalized services for monoclonal and polyclonal antibody development. It was founded in 2000, and now it is a global leader in delivering solutions for therapeutic and research purposes. It is also equipped to tackle antibody requirements for oncology, immunology, and regenerative medicine. The deal with academic research centers and worldwide pharma companies.
Media Contact:
Precision Antibody
Dr. Jun Hayashi
President
Phone: 410-884-4100
Email: info@precisionantibody.com
Website: www.precisionantibody.com
Event Details:
Drug Discovery Strategic Summit (DDSS)
Dates: April 30 – May 1, 2025
Venue: Boston, MA
Event Website: https://ddss.agilefalconsg.com/
Source: Precision Antibody
0 Comments
Latest on Marylandian
- Harvard Educated Board Certified Endodontist Joins Pearlfection Dentistry
- NYC Banners Delivers High-Stakes UN General Assembly Backdrop for the US Department of State Event
- OneVizion Appoints Energy Infrastructure Executive Walt Farrell to Board of Directors
- FlipTarot Launches Free AI-Powered Tarot Reading Website — 3 Free Readings Daily, No Signup Required
- Tampa Bay Reporter Launches with a Mission to Deliver Local News with National Reach
- "JACKIE the STRIPPER," Starring Charlotte Kirk and The PUSSYCAT DOLLS' Kimberly Wyatt, Now Streaming on PRIME
- Migguel Anggelo Celebrates the Immigrant Experience, Latino Identity, and the Power of Iconic Latin Rhythms During Hispanic Heritage Month
- Indianapolis Criminal Defense Firm Rigney Law LLC Relaunches Criminal Law Podcast "Tales from the Brown Desk"
- Filmmaking Heads Across the Country Inspire at the 10th Imagination Lunchbox International Film Fest
- 3ptechies Makes Its Articles Audio-Ready With Instaread Voice Technology
- Genuine Hospitality, LLC Selected to Operate Fairfield Inn & Suites Tampa Wesley Chapel
- Pregis to Highlight EPR Expertise, Sustainable Packaging Solutions and Live Automation Demonstrations at Pack Expo International 2026
- Maryland Horse Industry Board Meeting Notice
- Infinity Infusion Solutions Launches "Women Leading Infusion Care" Campaign for National Women in Business Month
- HuskyTail Digital Puts AI to Work Behind the Scenes to Cut Client Turnaround Time
- AI, Real-World Data "RWD" and U.S. Expansion Put Predictive Healthcare in Focus for POMDOCTOR Ltd. (N A S D A Q: POM)
- $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
- P-Wave Classics to publish Thomas Holcroft's The Adventures of Hugh Trevor in three volumes, beginning 19 January
- Ad Leverage Sponsors ServiceTitan Pantheon 2026, Supporting Education and Growth in the Home Services Industry
- DBF Viewer 2000 v9.32 Adds New Control for Data Export